Two new Pharmaceutical Inspection Co-Operation Scheme (PIC/S) guidance documents entered into force on 1 June 2020, a questions and answers guidance on implementing risk-based prevention of cross-contamination and an aide-memoire on health-based exposure limit (HBEL) assessments.
In case of any questions or if you seek experienced support to achieve GMP compliance, please, contact us for further information: info@smart-pharma.group
For the full text documents, please, follow the links below:
PI 052-1 Health Based Exposure Limit Aide-Memoire.pdf
PI 053-1 HBEL QA.pdf